Cassava Sciences, Alzheimer
Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials.
Drug development should focus on the disease’s causal pathways rather than consequences.
Breakthrough is going to help treatment and drug trials, scientists say Charles Marshall thinks he can now predict who will get dementia up to nine years before their symptoms appear, with a ...
Amyloid immunotherapies took 20 years to reach the clinic. Scientists are testing new types of therapies they hope could deliver stronger benefits and fewer side effects This article was produced ...
Journal Editorial Report: The week's best and worst from Bill McGurn, Allysia Finley, Mene Ukueberuwa and Dan Henninger. Image: Cristobal Herrera-Ulashkevich ...
Boston researchers say they’ve created a promising AI model that predicts the likelihood of someone developing Alzheimer’s ...
Federal health advisers have endorsed a closely watched Alzheimer’s drug from Eli Lilly for people with mild dementia WASHINGTON -- A closely watched Alzheimer's drug from Eli Lilly won the ...
In a promising study for Alzheimer's disease, scientists in Japan say they have reversed the signs of this debilitating ...
Developing new medicines entails enormous risk and perseverance. Take Eli Lilly’s Alzheimer’s disease treatment donanemab, which a Food and Drug Administration advisory committee on Monday ...
Hoau-Yan Wang, a 67-year-old tenured medical professor, was indicted this week for an alleged scheme involving fraudulent ...